New York, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Stem Cells Industry" - https://www.reportlinker.com/p02043289/?utm_source=GNW
1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 6.9% CAGR
The Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.We bring years of research experience to this 16th edition of our report. The 162-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- apceth Biopharma GmbH
- Athersys Inc.
- AVIVA BioSciences Corporation
- BioE Inc.
- Bone Therapeutics SA
- Cesca Therapeutics Inc.
- Cryo-Cell International Inc.
- Cytori Therapeutics Inc.
- ESI BIO
- Gamida Cell Ltd.
- Holostem Terapie Avanzate
- International Stem Cell Corp.
- Kangstem Biotech. Ltd.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Neuralstem Inc.
- Nuvasive Inc.
- OncoMed Pharmaceuticals Inc.
- Osiris Therapeutics Inc.
- Promethera Biosciences S.A.N.V
- Reliance Life Sciences
- ReNeuron Group Plc.
- Stemcell Technologies Inc.
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd.
- Takara Bio USA Inc.
- TiGenix NV
- U.S Stem Cell Inc.
- ViaCord
Read the full report: https://www.reportlinker.com/p02043289/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Stem Cells - Offering Potential for Breakthrough Therapeutic
Discoveries
Recent Market Activity
Select Approved Stem Cell Products
Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
Trends Related to Stem Cell Clinical Trials
Select Stem Cell Pipeline Analysis
Current & Future Analysis
Stem Cell Research Funding Policies across the World
Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC)
Research
Adult Stem Cells Deemed More Ethical, More Research Needed to
Increase Clinical Applications
Dental Mesenchymal Stem Cells - Emergence of a Niche Market
For-Profit, Unregulated Clinics: The Flipside of Stem Cell
Research
Unproven Therapies Do Online Rounds as Effective Treatment
Options - A Cause of Concern
Global Competitor Market Shares
Stem Cells Competitor Market Share Scenario Worldwide (in %):
2020 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Athersys, Inc. (USA)
Apceth GmbH & Co.KG (Germany)
AVIVA BioSciences Corporation (USA)
BioE, Inc. (USA)
Bone Therapeutics SA (Belgium)
Cesca Therapeutics, Inc. (USA)
Cryo-Cell International, Inc. (USA)
Cytori Therapeutics, Inc. (USA)
ESI BIO, a Division of BioTime Inc. (USA)
Gamida Cell Ltd. (Israel)
Holostem Terapie Avanzate (Italy)
International Stem Cell Corporation (USA)
Kangstem Biotech., Ltd. (Korea)
Lonza Group Ltd (Switzerland)
Mesoblast Ltd. (Australia)
Neuralstem, Inc. (USA)
Nuvasive, Inc. (USA)
Osiris Therapeutics, Inc. (USA)
OncoMed Pharmaceuticals, Inc (USA)
PROMETHERA Biosciences S.A.N.V (Belgium)
Reliance Life Sciences (India)
ReNeuron Group Plc. (UK)
STEMCELL Technologies, Inc. (Canada)
Stemedica Cell Technologies, Inc (USA)
Stempeutics Research Pvt. Ltd. (India)
Takara Bio USA Inc (USA)
TiGenix NV (Belgium)
U.S Stem Cell, Inc. (USA)
ViaCord, LLC (USA)
3. MARKET TRENDS & DRIVERS
Researchers at UCLA Successfully Develop 3D Lung Organoids
using Stem Cells
Embryonic Stem Cell Gene Nanog Found to Reverse Aging
Canadian and Dutch Scientists Finds the ?Genetic Switch? to
Increase Stem Cell Volume from Cord Blood
The Boston Program Pioneers Cell-based Personalized Diabetes
Treatment
iPSCs Provide Valuable Source for Retinal Transplants and Other
Applications
Albumin-Free Culture of Pluripotent Stem Cells Enables
Application in Cardiac Disorders
Stem Cell Therapy - An Alternative to Orthopedic Surgery in
Younger Patients?
Application of Plant Stem Cells in Cosmetic Treatments - Myths
Busted
Adverse Reactions of Stem Cell-Face Lift Therapy
Stem Cell-Breast Enhancement
Other Innovations Using Stem Cells
New Stem Cell Software & Products
4. GLOBAL MARKET PERSPECTIVE
Table 1: Stem Cells Global Market Estimates and Forecasts in
US$ Million by Region/Country: 2020-2027
Table 2: Stem Cells Market Share Shift across Key Geographies
Worldwide: 2020 VS 2027
Table 3: Adult Stem Cells (Product Type) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 4: Adult Stem Cells (Product Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2020 VS 2027
Table 5: Other Product Types (Product Type) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027
Table 6: Other Product Types (Product Type) Market Sales
Breakdown by Region/Country in Percentage: 2020 VS 2027
Table 7: Regenerative Medicine (Application) Global Market
Estimates & Forecasts in US$ Million by Region/Country:
2020-2027
Table 8: Regenerative Medicine (Application) Market Share
Breakdown by Region/Country: 2020 VS 2027
Table 9: Drug Discovery & Development (Application) Demand
Potential Worldwide in US$ Million by Region/Country: 2020-2027
Table 10: Drug Discovery & Development (Application) Share
Breakdown Review by Region/Country: 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Stem Cells Market Share (in %) by Company: 2020 & 2025
Market Analytics
Table 11: United States Stem Cells Market Estimates and
Projections in US$ Million by Product Type: 2020 to 2027
Table 12: United States Stem Cells Market Share Breakdown by
Product Type: 2020 VS 2027
Table 13: United States Stem Cells Latent Demand Forecasts in
US$ Million by Application: 2020 to 2027
Table 14: Stem Cells Market Share Breakdown in the United
States by Application: 2020 VS 2027
CANADA
Table 15: Canadian Stem Cells Market Estimates and Forecasts in
US$ Million by Product Type: 2020 to 2027
Table 16: Stem Cells Market in Canada: Percentage Share
Breakdown of Sales by Product Type for 2020 and 2027
Table 17: Canadian Stem Cells Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 18: Canadian Stem Cells Market Share Analysis by
Application: 2020 VS 2027
JAPAN
Table 19: Japanese Market for Stem Cells: Annual Sales
Estimates and Projections in US$ Million by Product Type for
the Period 2020-2027
Table 20: Japanese Stem Cells Market Share Analysis by Product
Type: 2020 VS 2027
Table 21: Japanese Demand Estimates and Forecasts for Stem
Cells in US$ Million by Application: 2020 to 2027
Table 22: Stem Cells Market Share Shift in Japan by
Application: 2020 VS 2027
CHINA
Table 23: Chinese Stem Cells Market Growth Prospects in US$
Million by Product Type for the Period 2020-2027
Table 24: Chinese Stem Cells Market by Product Type: Percentage
Breakdown of Sales for 2020 and 2027
Table 25: Chinese Demand for Stem Cells in US$ Million by
Application: 2020 to 2027
Table 26: Chinese Stem Cells Market Share Breakdown by
Application: 2020 VS 2027
EUROPE
Market Facts & Figures
European Stem Cells Market: Competitor Market Share Scenario:
(in %) for 2020 & 2025
Market Analytics
Table 27: European Stem Cells Market Demand Scenario in US$
Million by Region/Country: 2018-2025
Table 28: European Stem Cells Market Share Shift by
Region/Country: 2020 VS 2027
Table 29: European Stem Cells Market Estimates and Forecasts in
US$ Million by Product Type: 2020-2027
Table 30: European Stem Cells Market Share Breakdown by Product
Type: 2020 VS 2027
Table 31: European Stem Cells Addressable Market Opportunity in
US$ Million by Application: 2020-2027
Table 32: European Stem Cells Market Share Analysis by
Application: 2020 VS 2027
FRANCE
Table 33: Stem Cells Market in France by Product Type:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 34: French Stem Cells Market Share Analysis by Product
Type: 2020 VS 2027
Table 35: Stem Cells Quantitative Demand Analysis in France in
US$ Million by Application: 2020-2027
Table 36: French Stem Cells Market Share Analysis: A 7-Year
Perspective by Application for 2020 and 2027
GERMANY
Table 37: Stem Cells Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Product Type for the
Period 2020-2027
Table 38: German Stem Cells Market Share Breakdown by Product
Type: 2020 VS 2027
Table 39: Stem Cells Market in Germany: Annual Sales Estimates
and Forecasts in US$ Million by Application for the Period
2020-2027
Table 40: Stem Cells Market Share Distribution in Germany by
Application: 2020 VS 2027
ITALY
Table 41: Italian Stem Cells Market Growth Prospects in US$
Million by Product Type for the Period 2020-2027
Table 42: Italian Stem Cells Market by Product Type: Percentage
Breakdown of Sales for 2020 and 2027
Table 43: Italian Demand for Stem Cells in US$ Million by
Application: 2020 to 2027
Table 44: Italian Stem Cells Market Share Breakdown by
Application: 2020 VS 2027
UNITED KINGDOM
Table 45: United Kingdom Market for Stem Cells: Annual Sales
Estimates and Projections in US$ Million by Product Type for
the Period 2020-2027
Table 46: United Kingdom Stem Cells Market Share Analysis by
Product Type: 2020 VS 2027
Table 47: United Kingdom Demand Estimates and Forecasts for
Stem Cells in US$ Million by Application: 2020 to 2027
Table 48: Stem Cells Market Share Shift in the United Kingdom
by Application: 2020 VS 2027
REST OF EUROPE
Table 49: Rest of Europe Stem Cells Market Estimates and
Forecasts in US$ Million by Product Type: 2020-2027
Table 50: Rest of Europe Stem Cells Market Share Breakdown by
Product Type: 2020 VS 2027
Table 51: Rest of Europe Stem Cells Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 52: Rest of Europe Stem Cells Market Share Analysis by
Application: 2020 VS 2027
ASIA-PACIFIC
Table 53: Stem Cells Market in Asia-Pacific by Product Type:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 54: Asia-Pacific Stem Cells Market Share Analysis by
Product Type: 2020 VS 2027
Table 55: Stem Cells Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2020-2027
Table 56: Asia-Pacific Stem Cells Market Share Analysis:
A 7-Year Perspective by Application for 2020 and 2027
REST OF WORLD
Table 57: Rest of World Stem Cells Market Estimates and
Forecasts in US$ Million by Product Type: 2020 to 2027
Table 58: Stem Cells Market in Rest of World: Percentage Share
Breakdown of Sales by Product Type for 2020 and 2027
Table 59: Rest of World Stem Cells Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 60: Rest of World Stem Cells Market Share Analysis by
Application: 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 66
Read the full report: https://www.reportlinker.com/p02043289/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________